Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CAMECA is a global leader in the design and manufacture of high-end analytical instrumentation for microanalysis and metrology. The company provides advanced solutions for life sciences, materials science, and semiconductor industries, specializing in technologies such as Secondary Ion Mass Spectrometry (SIMS) and Atom Probe Tomography (APT). In the life sciences sector, CAMECA's NanoSIMS technology is widely utilized for high-resolution imaging of metabolic processes and drug distribution at the cellular and subcellular levels. As a subsidiary of AMETEK, CAMECA supports researchers worldwide with tools that enable precise chemical and isotopic mapping. Their instruments are essential for cutting-edge research in cell biology, microbiology, and pharmacology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CAMECA.